Discrete plasmapheresis for coronary heart disease
AIM. To provide a rationale for the expediency and efficiency of discrete plasmapheresis (PA) in the package of therapeutic measures for coronary heart disease (CHD). MATERIALS AND METHODS. 585 sessions or 120 cycles of low-volume therapeutic PA were performed in 91 patients with CHD. The parameters...
Main Authors: | I N Solov'eva, Iu E Mikhaĭlov, M Iu Andrianova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2014-08-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31523 |
Similar Items
-
Plasmapheresis in the ICU
by: Guleid Hussein, et al.
Published: (2023-12-01) -
TRADITIONAL AND CASCADE PLASMAPHERESIS IN ANTIBODY TITERS’ REDUCTION IN RENAL TRANSPLANT RECIPIENTS
by: A.V. Vatazin, et al.
Published: (2014-05-01) -
Therapeutic Plasmapheresis: Seven Year Experience of an Intensive Care Unit in Portugal
by: Rita Faria, et al.
Published: (2022-03-01) -
Hypertriglyceridemia Induced Pancreatitis Treated with Medical Management without Plasmapheresis
by: Ushna Naveed, et al.
Published: (2021-06-01) -
Plasmapheresis for a Patient with Catatonia and Systemic Lupus Erythematosus: A Case Report and Literature Review
by: Pei-Shan Tsai, et al.
Published: (2022-11-01)